Alta Natural Herbs & Supplements: Hepatico Research and Marketing Agreement Reached.SEATTLE--(BW HealthWire)--Nov. 18, 1998--Alta Natural (Alberta Stock Exchange Alberta Stock Exchange See Canadian Venture Exchange (CDNX). :AHS AHS Assistant House Surgeon. .) Company President, Adolf Huckschlag reports that the first stage of an anticipated multi-part research and marketing agreement has been reached between The Company and Continental Health Care Inc. of Cleveland, Ohio "Cleveland" redirects here. For the Cleveland metropolitan area, see . For other uses, see Cleveland (disambiguation). Cleveland is a city in the U.S. state of Ohio and the county seat of Cuyahoga County, the most populous county in the state. . Continental is a nationwide leader in specialty pharmacy care that is dedicated to providing a unique disease management approach to treating patients with challenging health conditions and long term medication needs such as pre and post transplantation, hepatitis, renal and diabetic care, cancer, HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome , and select high cost medicines whose outcomes, costs, and quality of life are enhanced by their services. "I am excited about the opportunity to introduce Hepatico to the US market and investigate the efficacy of this alternative treatment for various forms of liver dysfunction. We will begin researching the necessary study design and protocol to begin a clinical test of Hepatico as soon as possible," said Nicholas J. Opalich, Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Continental. The agreement provides continental Health Care with a US franchise to distribute Alta Natural's newly launched nutraceutical nu·tra·ceu·ti·cal n. A food or naturally occurring food supplement thought to have a beneficial effect on human health. nutraceutical product, Hepatico. Hepatico will be made available to US patients through Continental's toll free telephone number at 1-800-776-4633 or by fax at 1-800-333-1277. Continental will initially distribute Hepatico to their hepatitis patients throughout the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . Continental will also investigate the potential for further clinical trials to determine the value of Hepatico as a treatment for liver dysfunction. Continental has coordinated similar trials on Interferon/Ribavirin with Schering, as well as other experimental medications with major pharmaceutical companies. Negotiations are ongoing between Alta Natural Herbs & Supplements Ltd. And Continental Healthcare Inc. to expand the nature of their relationship. Further information will be available as these expanded negotiations conclude. The Alberta Stock Exchange has neither approved nor disapproved the contents of this release. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion